- OVERVIEW
- PRODUCTS
- Casting & Splinting
- Hand Hygiene
- Patient Monitoring
- Securement and Immobilization
- Skin Care
- Wound Care
- Sterilization & Monitoring
- Surgical Solutions
- Vascular Access
- View all
- CONDITIONS
- Bloodstream Infections
- Incision Management
- Surgical Site Infections
- Incontinence-Associated Dermatitis
- Pressure Injury Prevention
- Wound Care
- EDUCATION
- SUPPORT
-
The impact of SARS-CoV² has everyone trying to manage patient care with a sharp eye on resources. With a focus on OR efficiency, minimizing prolonged stays and reducing readmissions and preventable complications is vital to patient flow and facility economics. As you look for solutions that provide extended value, it may be time to consider how PREVENA™ Therapy protects you, your patients, and your practice well beyond the incision site.
The Power of PREVENA™ Therapy
-
PREVENA™ Therapy can aid in reducing the costly financial burden of complications such as SSI’s.
-
The most clinically validated closed incision negative pressure therapy with over 80+ publications and growing
-
PREVENA™ Therapy is the first and only medical device indicated by FDA to help reduce superficial surgical site infections in high-risk patients in Class I and II wounds*
Request a consultation with a 3M PREVENA™ Therapy Representative
REQUEST A CONSULTATIONThank You
Your form was submitted successfully!
Our Apologies...
An error has occurred while submitting. Please try again later...
-
Orthopedic Outcomes -
Vascular Outcomes -
Plastic Outcomes
PREVENA™ Therapy is uniquely engineered to empower incision management that works to protect patients, surgeons, staff, practices, and hospitals during the SARS-CoV-2 pandemic.
-
PREVENA™ Therapy for PatientsAccess information and patient stories to share with your patients.
-
Medical Education
Call us on 1800 742 9929
Call us on 1800 742 9929
-
*PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible dressings, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma and, in patients at risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and II wounds. The effectiveness of PREVENA™ Therapy in reducing the incidence of SSIs and seroma in all surgical procedures and populations has not been demonstrated. See full indications for use and limitations at ##discLink1##.
